104 related articles for article (PubMed ID: 14632362)
1. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study.
Weigl M; Gschwantler M; Gatterer E; Finsterer J; Stöllberger C
South Med J; 2003 Nov; 96(11):1128-32. PubMed ID: 14632362
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
3. Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study.
de Bortoli N; Guidi G; Martinucci I; Savarino E; Imam H; Bertani L; Russo S; Franchi R; Macchia L; Furnari M; Ceccarelli L; Savarino V; Marchi S
Dis Esophagus; 2016; 29(2):197-204. PubMed ID: 25516110
[TBL] [Abstract][Full Text] [Related]
4. Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis.
Nakamura H; Nakaji G; Shimazu H; Yasuda S; Odashiro K; Maruyama T; Kaji Y; Chishaki A
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):270-6. PubMed ID: 17665548
[TBL] [Abstract][Full Text] [Related]
5. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
von Renteln D; Brey U; Riecken B; Caca K
Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
[TBL] [Abstract][Full Text] [Related]
8. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Gastroesophageal Reflux Disease and Proton Pump Inhibitor Use on the Risk of Repeat Catheter Ablation for Atrial Fibrillation.
Cai JX; Algara M; Lo WK; Kapur S; Chan WW
Clin Transl Gastroenterol; 2024 Jun; 15(6):e00717. PubMed ID: 38752627
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.
Van Meer S; Bogte A; Siersema PD
Scand J Gastroenterol; 2013 Nov; 48(11):1242-8. PubMed ID: 24041112
[TBL] [Abstract][Full Text] [Related]
11. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease.
Hershcovici T; Jha LK; Gadam R; Cui H; Gerson L; Thomson S; Fass R
J Clin Gastroenterol; 2012 Sep; 46(8):662-8. PubMed ID: 22858518
[TBL] [Abstract][Full Text] [Related]
12. Objective Evaluation of Gastroesophageal Reflux Disease in Patients with Paroxysmal Atrial Fibrillation.
Coutinho EL; Herbella FAM; Lovato CAV; Patti MG; Schlottmann F; de Paola AAV
World J Surg; 2018 May; 42(5):1458-1462. PubMed ID: 29134307
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
15. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
17. [A study of extraesophageal presentations in gastroesophageal reflux disease].
Li ZS; Xu XR; Zou DW; Xie WF; Yu XF; Chen XM; Lin Y; Xia J; Zhu FS; Wen W; Su T
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):13-6. PubMed ID: 16624080
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic esophagitis is more severe in gastroesophageal reflux patients with a positive family history.
Tsibouris P; Moussia M; Kalantzis C; Apostolopoulos P; Alexandrakis G; Lapas C; Kalantzis N
J Clin Gastroenterol; 2012 Mar; 46(3):201-8. PubMed ID: 22138842
[TBL] [Abstract][Full Text] [Related]
20. Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy.
Shaheen NJ; Denison H; Björck K; Silberg DG
Am J Gastroenterol; 2013 Apr; 108(4):529-34. PubMed ID: 23318482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
